Let’s talk about statins. I know… boring, right? Most of us already know a lot about them. But thinking of statins only as cholesterol drugs misses the bigger picture.In many ways, statins are best understood as anti-atherosclerotic t...

In this special LipidCurious Inspiration episode, Dr. Vishnu Priya Pulipati, MD, FACE, DiplABCL, sits down with legendary lipid educator Dr. Thomas Dayspring, MD, FACP, FNLA, for a conversation beyond guidelines and numbers. Toget...

ASCVD prevention isn’t about numbers; it’s about extending healthy years.  Treat the right individual, at the right time, with the right intensity, and you give them more shared birthdays, more anniversaries, and more ordinary Tuesday dinn...

ASCVD risk stratification gets messy fast—especially when calculators, risk enhancers, and coronary calcium scores all compete for attention. In Part 2 of the LipidCurious ASCVD Risk Stratification mini-series, we focus on how to use the...

ASCVD risk stratification should be straightforward, but in real clinic time, it often isn’t. Multiple guidelines, limited time, overlapping categories, and nonstop competing priorities make lipid decisions feel harder than they need to be....